SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
40 hedge funds and large institutions have $75.9M invested in Sinovac Biotech, Ltd in 2013 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
47% less call options, than puts
Call options by funds: $175K | Put options by funds: $330K
Holders
40
Holding in Top 10
–
Calls
$175K
Puts
$330K
Top Buyers
| 1 | +$6.04M | |
| 2 | +$2.78M | |
| 3 | +$969K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$370K |
| 5 |
WC
Wexford Capital
West Palm Beach,
Florida
|
+$343K |
Top Sellers
| 1 | -$1.8M | |
| 2 | -$1.51M | |
| 3 | -$1.32M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.05M |
| 5 |
Morgan Stanley
New York
|
-$569K |